Olivier Gerrit de Jong
Overview
Explore the profile of Olivier Gerrit de Jong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
17
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Walther J, Porenta D, Wilbie D, Seinen C, Benne N, Yang Q, et al.
Eur J Pharm Biopharm
. 2024 Feb;
196:114207.
PMID: 38325664
The discovery that the bacterial defense mechanism, CRISPR-Cas9, can be reprogrammed as a gene editing tool has revolutionized the field of gene editing. CRISPR-Cas9 can introduce a double-strand break at...
2.
van de Wakker S, Bauza-Martinez J, Rios Arceo C, Manjikian H, Snijders Blok C, Roefs M, et al.
J Extracell Vesicles
. 2024 Jan;
13(1):e12396.
PMID: 38179654
Cardiac progenitor cell (CPC)-derived small extracellular vesicles (sEVs) exhibit great potential to stimulate cardiac repair. However, the multifaceted nature of sEV heterogeneity presents a challenge in understanding the distinct mechanisms...
3.
Raes L, Pille M, Harizaj A, Goetgeluk G, Van Hoeck J, Stremersch S, et al.
Mol Ther Nucleic Acids
. 2021 Sep;
25:696-707.
PMID: 34589287
The CRISPR-Cas9 technology represents a powerful tool for genome engineering in eukaryotic cells, advancing both fundamental research and therapeutic strategies. Despite the enormous potential of the technology, efficient and direct...